Acetylcarnitine
- Generic Name
- Acetylcarnitine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H17NO4
- CAS Number
- 3040-38-8
- Unique Ingredient Identifier
- 6DH1W9VH8Q
- Background
Acetylcarnitine is an investigational drug in the United states, Italy, United Kingdom, China, Israel, and Norway, and it is approved in Italy, Portugal, Argentina, Chile, Philippines, Australia, and India. Acetylcarnitine can be synthesized, but it is also naturally found in adequate amounts in healthy humans. In human plasma and tissues, acetylcarnitine is...
- Indication
Acetylcarnitine is not approved for any indication in the United states and Canada, but it is approved and indicated in Italy for cerebrovascular disorders, mental function disorders, peripheral nerve disorders, diabetic neuropathy, and nutritional supplementation; Portugal for mental function disorders; Argentina for cerebral vasculopathy, nutritional suppl...
- Associated Conditions
- Peripheral nerve lesion
- Associated Therapies
- -
Effect of Acetyl-L-carnitine in Migraine
- First Posted Date
- 2012-09-27
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Norwegian University of Science and Technology
- Target Recruit Count
- 72
- Registration Number
- NCT01695317
- Locations
- ๐ณ๐ด
Norwegian National Headache Centre, Trondheim, Norway
Clinical Study on Acetyl-L-Carnitine
- Conditions
- Interventions
- First Posted Date
- 2012-02-06
- Last Posted Date
- 2013-11-11
- Lead Sponsor
- Lee's Pharmaceutical Limited
- Target Recruit Count
- 239
- Registration Number
- NCT01526564
Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2011-06-23
- Last Posted Date
- 2015-04-24
- Target Recruit Count
- 107
- Registration Number
- NCT01379976
- Locations
- ๐ฎ๐น
Azienda Ospedaliera San Paolo, Milano, Italy
๐ฎ๐นAzienda Ospedaliera Ospedale Civile di Legnano, Legnano, Italy
๐ฎ๐นAzienda Ospedaliera Istituti Ospitalieri, Cremona, Italy
Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
- Conditions
- Interventions
- First Posted Date
- 2010-10-19
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- University of Catania
- Target Recruit Count
- 67
- Registration Number
- NCT01223729
- Locations
- ๐ฎ๐น
Cannizzaro Hospital, Catania, Italy
Acetyl-L-Carnitine In Severe Hepatic Encephalopathy
- Conditions
- Interventions
- First Posted Date
- 2010-10-19
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- University of Catania
- Registration Number
- NCT01223768
- Locations
- ๐ฎ๐น
Cannizzaro Hospital, Catania, Italy
Acetyl-L-Carnitine in the Treatment of Septic Shock
- First Posted Date
- 2008-01-14
- Last Posted Date
- 2017-12-08
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 13
- Registration Number
- NCT00592488
- Locations
- ๐บ๐ธ
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy
- Conditions
- First Posted Date
- 2002-12-04
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 27
- Registration Number
- NCT00050271
- Locations
- ๐บ๐ธ
Beth Israel Med. Ctr., ACTU, New York, New York, United States
๐บ๐ธCook County Hosp. CORE Ctr., Chicago, Illinois, United States
๐บ๐ธThe Ponce de Leon Ctr. CRS, Atlanta, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.